Jean-Manassé Theagene (he/him)

CEO and President Jean-Manassé Theagene, brings with him an impressive 20 years of success in pharmaceutical marketing and digital health.

He founded 360Medlink in 2010, raising it from the ground up into a dedicated team of fifty high level professionals who work to serve a diverse range of clients ranging from pharma, government agencies, and payers. Previous to that, he established Pharmxpand, a pioneer start-up that launched the first liver disease non-invasive diagnostic test.

Manassé holds an MSc in Criminology along with an MBA. In his very first international marketing role he chose to work on Subutex/Suboxone, today’s leading treatment for opioid addiction and pursued global oncology marketing at Novartis and in CNS/CV at Schering-Plough.

He is passionate about healthcare, technology, culture and empowering vulnerable populations to improve their quality of life.